Literature DB >> 12121977

Cell cycle promoting activity of JunB through cyclin A activation.

Sven Andrecht1, Andrea Kolbus, Bettina Hartenstein, Peter Angel, Marina Schorpp-Kistner.   

Abstract

JunB, a major component of the AP-1 transcription factor, is known to act antagonistically to c-Jun in transcriptional regulation and is proposed to be a negative regulator of cell proliferation. Employing fibroblasts derived from E9.5 junB(-/-) mouse embryos we provide evidence for a novel cell cycle promoting role of JunB. Despite a normal proliferation rate, primary and immortalized junB(-/-) fibroblasts exhibited an altered cell cycle profile, which was characterized by an increase in the population of S-phase cells, while that of cells in G(2)/M-phase was diminished. This delay in G(2)/M-transition is caused by impaired cyclin A-CDK2 and cyclin B-CDC2 kinase activities and counteracts the accelerated S-phase entry. Cells lacking JunB show severely delayed kinetics of cyclin A mRNA expression due to the loss of proper transcriptional activation mediated via binding of JunB to the CRE element in the cyclin A promoter. Upon reintroduction of an inducible JunB-ER(TM) expression vector the cell cycle distribution and the cell cycle-associated cyclin A-CDK2 kinase activity could be restored. Thus, cyclin A is a direct transcriptional target of JunB driving cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121977     DOI: 10.1074/jbc.M202847200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Generating chromosome instability through the simultaneous deletion of Mad2 and p53.

Authors:  Aurora A Burds; Annegret Schulze Lutum; Peter K Sorger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

2.  c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Authors:  Jane Y Jin; Hengning Ke; Russell P Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2011-02-03       Impact factor: 8.551

3.  Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Authors:  Dirk Schmidt; Björn Textor; Oliver T Pein; Alexander H Licht; Sven Andrecht; Melanie Sator-Schmitt; Norbert E Fusenig; Peter Angel; Marina Schorpp-Kistner
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

4.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

5.  A TSH-CREB1-microRNA loop is required for thyroid cell growth.

Authors:  Vincenza Leone; Daniela D'Angelo; Angelo Ferraro; Pierlorenzo Pallante; Ileana Rubio; Massimo Santoro; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Endocrinol       Date:  2011-08-04

6.  JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis.

Authors:  Rosa Farràs; Véronique Baldin; Sandra Gallach; Claire Acquaviva; Guillaume Bossis; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

Review 7.  Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.

Authors:  Alexandra Papoudou-Bai; Eleftheria Hatzimichael; Alexandra Barbouti; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2016-09-06       Impact factor: 3.984

8.  Double lethal effects of fusion gene of wild-type p53 and JunB on hepatocellular carcinoma cells.

Authors:  Cheng Guo; Qingguang Liu; Lei Zhang; Xue Yang; Tao Song; Yingmin Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10

9.  An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells.

Authors:  Tiphanie Gomard; Henri-Alexandre Michaud; Denis Tempé; Kevin Thiolon; Mireia Pelegrin; Marc Piechaczyk
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

10.  Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Authors:  Jennifer H Gutzman; Debra E Rugowski; Matthew D Schroeder; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2004-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.